A vascular graft is a surgical procedure that reconnects blood vessels and redirects blood flow from one part of the body to another. They are widely used for the surgery of vascular diseases.
A vascular graft is a surgical procedure that reconnects blood vessels and redirects blood flow from one part of the body to another. They are widely used for the surgery of vascular diseases. A vascular graft is a tube-shaped synthetic material that is surgically inserted into veins and arteries. The length and diameter of the graft depend on the type of artery or size of the vein. This surgery is used for bypass operations or to create easier vein access in hemodialysis patients. The advancements in materials have increased the success rate of graft implant surgeries.
According to Allied Market Research, the global vascular graft market is expected to reach $8.13 billion by 2030, growing at a CAGR of 4.98% from 2021 to 2030. Rise in vascular diseases including pulmonary embolism, deep vein thrombosis, atherosclerosis, and other cardiac disorders along with surge in number of surgery centers and hospitals drive the market growth.
Materials Used for Vascular Graft
Over the last few years, the leading companies in the vascular graft industry have launched biocompatible novel materials. One of the most promising materials is made from natural collagen. These are woven together to develop a very flexible small tube and it is used for hemodialysis. The vascular graft binds an artery and vein together to create a stable opening for dialysis treatment. Apart from this, polyurethane nano fabric materials are used to create dialysis access points. These materials close themselves after the dialysis needle is removed, which helps reduce blood leakage into surrounding tissues.
In the U.S., cardiovascular disease is the leading cause of mortality. While synthetic polymers have proven to be effective as a vascular graft, there is a dire need for substitutes in vascular engineering as the conventional graft materials fall short of meeting the biological challenges at the interface of blood and material. Thus, numerous tissue engineering strategies and novel materials have emerged to increase long-term patency and address the flaws in conventional vascular grafts.
Request for Sample Report for More Insights @ https://www.alliedmarketresearch.com/request-sample/2435
Top Leading Players:
The key players operating in the global vascular graft market include B. Braun Melsungen AG, Becton, Dickinson And Company, Cook Medical, Inc., Cordis, Endologix Inc., Getinge Group, LeMaitre Vascular Inc., Medtronic plc, Terumo Medical Corporation, and W. L. Gore & Associates, Inc.
Covid-19 Scenario-
Here, it’s worth mentioning that the outbreak of the Covid-19 pandemic led to postponement of vascular graft procedures, thereby resulting in decreased demand for vascular graft from the healthcare sector. This factor had a negative impact on the global market, especially during the initial phase. However, the situation has almost gotten back to normalcy and high-end innovations have also been incorporated by the key players. With this drift on board, the market is anticipated to revive really soon.
The emergence of biomaterials has revolutionized vascular graft surgeries. The generation of protein polymers that adopt the nature of arteries and mimic native structural proteins have unlocked new opportunities in the market. The collagen and fibrin gels effectively bind to vital proteins and are proven to be ideal in formation of artificial blood vessels. Thus, in the future, more R&D would carry on to improve current biomaterials and increase their potency.